Key result
Targeting endogenous transmitter systems presents a novel mechanistic strategy for arrhythmia prevention and treatment.
Answers are grounded in this paper and cite their sources.
This review highlights the presence and function of endogenous transmitter systems in the heart, proposing a novel transmitter-based model for cardiac bioelectric regulation and arrhythmia management.
Transmitter systems are molecular networks that facilitate signal transmission between neurons or between neurons and effector cells. Well-established examples include the glutamatergic, cholinergic, GABAergic, dopaminergic, serotonergic, and histaminergic systems. Traditionally, the heart was thought to lack its own endogenous transmitter systems (ETSs). However, recent studies have identified several such systems within cardiomyocytes and cardiac pacemaker cells. This review focuses on the endogenous glutamatergic, cholinergic, and GABAergic systems in the heart, providing a comprehensive analysis of their molecular composition, electrophysiological functions, arrhythmogenic implications, and therapeutic potential. Based on these findings, this review proposes a transmitter-based model of cardiac bioelectric regulation and highlights innovative strategies for targeting ETSs to prevent and treat arrhythmias.
No takes yet. Share an insight, caveat, or question.
Xie et al. (2025) conducted a review in Arrhythmias. Endogenous transmitter systems (ETSs) was evaluated. This review proposes a transmitter-based model of cardiac bioelectric regulation and highlights innovative strategies for targeting endogenous transmitter systems to prevent and treat arrhythmias.
Synapse has enriched 10 related papers. Consider them for comparative context: